{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:00:27Z","timestamp":1790820027292,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002753","name":"Universidad Nacional de Colombia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijgc.2025.102021","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:05:58Z","timestamp":1753484758000},"page":"102021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Silicon dioxide, sodium selenite and citric acid vaginal gel, HPV infection, and cervical preinvasive disease: a narrative review"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-5796","authenticated-orcid":false,"given":"Emmanuel S\u00e1nchez","family":"D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-5379","authenticated-orcid":false,"given":"Gabriel","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7697-4915","authenticated-orcid":false,"given":"Beatriz","family":"Aristizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0589-2696","authenticated-orcid":false,"given":"Andre\u00edna","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4815-3914","authenticated-orcid":false,"given":"Florencia","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cant\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-4216","authenticated-orcid":false,"given":"Fernando","family":"Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0217-6574","authenticated-orcid":false,"given":"Helena M.","family":"Obermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0093-0438","authenticated-orcid":false,"given":"Rene","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2025.102021_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102021_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","article-title":"The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: A systematic review and meta-analysis","volume":"25","author":"Loopik","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102021_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102021_bib4","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.3390\/ijerph20043630","article-title":"The impact of HPV diagnosis and abnormal cervical cytology results on sexual dysfunction and anxiety","volume":"20","author":"Aker","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijgc.2025.102021_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2023.107810","article-title":"Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: \u201cThe land of the unknown.\u201d","volume":"114","author":"Kohler","year":"2023","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.ijgc.2025.102021_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejogrb.2024.09.019","article-title":"Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen: A systematic review and meta-analysis","volume":"302","author":"McGee","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijgc.2025.102021_bib7","article-title":"Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2\u20133: A narrative review","volume":"33","author":"Desravines","year":"2020","journal-title":"Gynecol Oncol Rep"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102021_bib8","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/S2666-5247(23)00257-4","article-title":"Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement","volume":"5","author":"Mitra","year":"2024","journal-title":"Lancet Microbe"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102021_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/taap.1999.8793","article-title":"Silica binds serum proteins resulting in a shift of the dose-response for silica-induced chemokine expression in an alveolar Type II cell line","volume":"161","author":"Barrett","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102021_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/aem.37.3.480-486.1979","article-title":"Degradation of poliovirus by adsorption on inorganic surfaces","volume":"37","author":"Murray","year":"1979","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102021_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ijgc.2025.102021_bib12","series-title":"Use of Selenite-Containing Compounds to Be Topically or Buccally Administered","author":"Kuklinski","year":"2008"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102021_bib13","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1055\/s-0042-105286","volume":"76","author":"Huber","year":"2016","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10.1016\/j.ijgc.2025.102021_bib14","article-title":"An adsorptive and antioxidant vaginal gel clears high-risk hpv- and p16\/ki-67-associated abnormal cytological cervical findings: a post-hoc subgroup analysis of a prospective randomized controlled trial on CIN2 and p16 positive CIN1","volume":"8","author":"Major","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102021_bib15","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.3390\/jcm12124142","article-title":"Successful preventive treatment of oncogenic transforming HPV infections in low-grade cytology (ASC-US\/LSIL) patients with an adsorptive and antioxidant vaginal gel","volume":"12","author":"Major","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijgc.2025.102021_bib16","author":"Lomas","year":"2024","journal-title":"Universidad Aut\u00f3noma de Aguas Calientes"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102021_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5152\/jtgga.2015.0147","article-title":"Method comparison between Munich II and III nomenclature for Pap smear samples","volume":"16","author":"Cirkel","year":"2015","journal-title":"J Turk Ger Gynecol Assoc."},{"issue":"2","key":"10.1016\/j.ijgc.2025.102021_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00404-020-05816-8","article-title":"Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16\/Ki-67: a randomized controlled trial","volume":"303","author":"Major","year":"2021","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102021_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00404-020-05925-4","article-title":"Correction to: efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16\/Ki-67: a randomized controlled trial","volume":"303","author":"Major","year":"2021","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102021_bib20","first-page":"A8.2","article-title":"2022-RA-421-ESGO DeflaGyn\u00ae has cytotoxic, genotoxic and apoptotic effects on human adenocancer cells: an in vitro study","volume":"35","author":"Gokmen Karasu","year":"2022","journal-title":"Cervical Cancer"},{"issue":"suppl 1","key":"10.1016\/j.ijgc.2025.102021_bib21","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.ijgc.2025.102021_bib22","series-title":"The Cochrane Collaboration for Quality Assessment of Randomized Controlled Trials","article-title":"Chapter 8. Assessing risk of bias in a randomized trial","author":"Higgins","year":"2025"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102021_bib23","doi-asserted-by":"crossref","first-page":"841e","DOI":"10.1097\/PRS.0000000000008946","article-title":"New pyramid proposal for the levels of scientific evidence according to SIGN","volume":"149","author":"Arieta-Miranda","year":"2022","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ijgc.2025.102021_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.socscimed.2017.12.005","article-title":"Understanding and misunderstanding randomized controlled trials","volume":"210","author":"Deaton","year":"2018","journal-title":"Soc Sci Med"},{"issue":"8","key":"10.1016\/j.ijgc.2025.102021_bib25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11121-021-01263-2","article-title":"Common methodological problems in randomized controlled trials of preventive interventions","volume":"22","author":"Steeger","year":"2021","journal-title":"Prev Sci"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102021_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0049475518798532","article-title":"Pap smear accuracy for the diagnosis of cervical precancerous lesions","volume":"49","author":"Nkwabong","year":"2019","journal-title":"Trop Doct."},{"issue":"20","key":"10.1016\/j.ijgc.2025.102021_bib27","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.2010.651","article-title":"Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes","volume":"303","author":"Boutron","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijgc.2025.102021_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102821","article-title":"Evaluation of spin in oncology clinical trials","volume":"144","author":"Wayant","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102021_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12916-017-0902-9","article-title":"Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?","volume":"15","author":"Kemp","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.ijgc.2025.102021_bib30","first-page":"109","article-title":"Post-trial follow-up methodology in large randomized controlled trials: a systematic review","volume":"14","author":"Baigent","year":"2013","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102021_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13063-018-2653-0","article-title":"Post-trial follow-up methodology in large randomised controlled trials: a systematic review","volume":"19","author":"Llewellyn-Bennett","year":"2018","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102021_bib32","first-page":"646","article-title":"A drug\u2019s life: the pathway to drug approval","volume":"11","author":"Keng","year":"2013","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ijgc.2025.102021_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.socscimed.2018.12.025","article-title":"Changing standards for drug approval: A longitudinal analysis of conditional marketing authorisation in the European Union","volume":"222","author":"Hoekman","year":"2019","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ijgc.2025.102021_bib34","unstructured":"Anti-HPV bio-gel dressing market. PW Consulting. Accessed July 6, 2025. https:\/\/pmarketresearch.com\/hc\/anti-hpv-bio-gel-dressing-market\/."},{"issue":"5","key":"10.1016\/j.ijgc.2025.102021_bib35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000517522","article-title":"The difference between approval processes for medicinal products and medical devices in Europe","volume":"244","author":"Marshall","year":"2021","journal-title":"Ophthalmologica"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102021_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacbts.2016.06.003","article-title":"Drugs and devices: comparison of European and U.S. approval processes","volume":"1","author":"Van Norman","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ijgc.2025.102021_bib37","unstructured":"Directive 2001\/83\/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. European Parliament and Council of the European Union. Accessed May 27, 2025. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32001L0083."},{"key":"10.1016\/j.ijgc.2025.102021_bib38","unstructured":"Regulation (EU) 2017\/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001\/83\/EC, Regulation (EC) No 178\/2002 and Regulation (EC) No 1223\/2009 and repealing Council Directives 90\/385\/EEC and 93\/42\/EEC (Text with EEA relevance.). European Parliament and Council of the European Union. Accessed May 25, 2025. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32017R0745."},{"issue":"2","key":"10.1016\/j.ijgc.2025.102021_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jama.2014.15939","article-title":"The anatomy of medical research: US and international comparisons","volume":"313","author":"Moses","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102021_bib40","first-page":"MR000033","article-title":"Industry sponsorship and research outcome","volume":"2","author":"Lundh","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102021_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025035","article-title":"Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea","volume":"9","author":"Lee","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102021_bib42","first-page":"1658","article-title":"Patients\u2019 anxiety and expectations: how they influence family physicians\u2019 decisions to order cancer screening tests","volume":"51","author":"Haggerty","year":"2005","journal-title":"Can Fam Physician"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102021_bib43","first-page":"1683","article-title":"Role of colposcopy after treatment for cervical intraepithelial neoplasia. Cancers (Basel)","volume":"12","author":"Heinonen","year":"2020"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102021_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2303.2008.00636.x","article-title":"European guidelines for clinical management of abnormal cervical cytology, part 2","volume":"20","author":"Jordan","year":"2009","journal-title":"Cytopathology"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102021_bib45","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.3390\/curroncol30060431","article-title":"2023 Canadian colposcopy guideline: A risk-based approach to management and surveillance of cervical dysplasia","volume":"30","author":"Willows","year":"2023","journal-title":"Curr Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25011417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25011417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:22:43Z","timestamp":1790817763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25011417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1048891X25011417"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102021","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silicon dioxide, sodium selenite and citric acid vaginal gel, HPV infection, and cervical preinvasive disease: a narrative review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102021"}}